APA (7th ed.) Citation

Kauffenstein, G., Chappard, D., Leftheriotis, G., & Martin, L. (2022). ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum? Experimental Dermatology, 31(10), 1635. https://doi.org/10.1111/exd.14636

Chicago Style (17th ed.) Citation

Kauffenstein, Gilles, Daniel Chappard, Georges Leftheriotis, and Ludovic Martin. "ABCC6 Deficiency and Bone Loss: A Double Benefit of Etidronate for Patient Presenting with Pseudoxanthoma Elasticum?" Experimental Dermatology 31, no. 10 (2022): 1635. https://doi.org/10.1111/exd.14636.

MLA (9th ed.) Citation

Kauffenstein, Gilles, et al. "ABCC6 Deficiency and Bone Loss: A Double Benefit of Etidronate for Patient Presenting with Pseudoxanthoma Elasticum?" Experimental Dermatology, vol. 31, no. 10, 2022, p. 1635, https://doi.org/10.1111/exd.14636.